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Purpose: To investigate whether the GLC1F locus is associated with normal tension glaucoma (NTG) in Japanese patients.
Methods: We recruited 242 unrelated Japanese subjects, including, 141 NTG patients and 101 healthy controls. The
patients exhibiting a comparatively early onset were selected as they suggest that genetic factors may show stronger
involvement. Genotyping and assessment of allelic diversity was performed on 11 highly polymorphic microsatellite
markers in and around the GLC1F locus.
Results: Individuals carrying the 163 allele of D7S1277i had a statistically significant increased risk of NTG (p=0.0013,
pc=0.016, OR=2.47, 95%CI=1.42–4.30). None of the other markers identified significant loci (pc>0.05) after Bonferroni’s
correction.
Conclusions: These findings suggested that the genes in the GLC1F locus may be associated with the pathogenesis of
NTG.
Glaucoma causes permanent damage of the retina and
optic nerve, leading to vision loss and blindness [1]. Primary
open-angle glaucoma (POAG) is the most common type of
glaucoma  and  normal  tension  glaucoma  (NTG)  is  an
important subset of POAG; while many POAG patients have
high  intraocular  pressure  (IOP)  [2],  NTG  patients  have
statistically normal IOP [3-5]. NTG is more prevalent in the
Asian population, in particular in the Japanese population
[6-8]. The diagnosis of glaucoma is based on a combination
of factors including optic nerve damage and specific field
defects,  with  IOP  being  the  only  treatable  risk  factor.
However, NTG is underdiagnosed: it usually presents late in
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life  after  loss  of  the  visual  field  because  it  may  be
asymptomatic with normal IOP.
Glaucoma is recognized as a multi-factorial disorder [9].
Many genes are associated with glaucoma, and several are
specifically involved in open-angle glaucoma [10-14]. The
GLC1F locus on chromosome 7q35-q36 is the sixth gene
locus for POAG [15].
Although NTG may be associated with the GLC1F locus,
such  an  association  has  not  been  investigated.  Thus,  we
performed microsatellite (MS) mapping around the GLC1F
locus in Japanese NTG patients.
METHODS
Subjects: We recruited 242 Japanese subjects from Yokohama
City  University,  Yamanashi  University,  Gifu  University,
Kobe  University,  Yamaguchi  University,  Kumamoto
University, Hokkaido University, Tokyo University, Niigata
University,  Kanazawa  University,  Hiroshima  University,
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462Tajimi Municipal Hospital, and Tokai University, all in Japan.
Of  these  subjects,  141  had  NTG,  and  101  were  control
subjects.  The  criteria  used  for  the  diagnosis  of  NTG  are
previously described [16]. The mean age of the patients was
47.30±1.29 years old, and the male: female ratio was 0.92.
The mean refraction value was −3.75±0.35 diopters (D), and
the mean deviation observed in the Humphrey® static visual
field  determination  (Carl  Zeiss  Meditec,  Oberkochen,
Germany) was –10.19±0.94 dB. The age- and sex-matched
controls  were  not  affected  by  glaucoma  or  any  local  or
systemic illnesses known to cause optic disc or visual field
changes. The control cases had no myopia or had mild myopia
with refractive errors of –3.00 D or less. Therefore, the groups
were somewhat different mean refraction errors. All subjects
had similar social background and resided in the same urban
area,  and  provided  informed  consent.  The  study  was
conducted in accordance with the Declaration of Helsinki and
subsequent revisions thereof.
Analysis of the 11 microsatelllite loci: Genomic DNA was
extracted from blood using the QIAamp DNA Blood Mini Kit
(Qiagen, Hilden, Germany) or with the standard guanidine
method. Eleven MS markers within the GLC1F locus were
Figure  1.  Location  of  the  11
microsatellite  markers  used  in  this
study. All the markers were located on
chromosome 7q35–36.
TABLE 1. PRIMER SEQUENCES OF 11 MICROSATELLITE MARKERS USED IN THIS STUDY.
Locus Dye Orientation Sequence (5′ to 3′)
D7S0324i FAM F TTTAACAGTTCACACCATGTAAATC
    R TTCGAAGCACTACCAAGTCTAC
D7S0960i PET F GCAATTGTATTCGTTTCATTAG
    R CATTACAGGCGTGAGCTAC
D7S0985i VIC F CTGGCTAACATGGTGAAAC
    R GAGAACCTCAGTTGAGGTAGAG
D7S1205i NED F TCTGCCTAGCACTAGAAAGAAG
    R GGCTCTGTTTACTATACTGGAGG
D7S0751i FAM F TGGCATAAGCTATTTGTATGTTTA
    R TACAGTGAGCTATGATGGCAC
D7S0796i NED F CGTATGGATACCTATGTAACAAAC
    R TAATTAGACCACATTTAACCAGAC
D7S505 VIC F ACTGGCCTGGCAGAGTCT
    R CAGCCATTCGAGAGGTGT
D7S1277i PET F TGTCTTCTGAGACTGTAAGATGTTC
    R TGGGAGAACAGTAGGATGG
D7S2439 FAM F CAGCAAAAGGTACAGCAATTTC
    R AAAGTCTACGCCGCATTC
D7S1126i FAM F CATGCTGAGCCTCAACTAC
    R CTGTTGGACTCGTACTAAGATTAC
D7S1828 PET F TCTTTCCTTTCCTGCATCAC
    R AGAATCTTGACATTATCTGACTTCA
Molecular Vision 2010; 16:462-466 <http://www.molvis.org/molvis/v16/a52> © 2010 Molecular Vision
463selected  based  on  the  National  Center  for  Biotechnology
Information (Figure 1). Polymerase chain reaction (PCR) was
performed in a 12.5 µl reaction mixture comprising PCR
buffer, genomic DNA, 0.2 mM dinucleotide triphosphates
(dNTPs), 0.5 µM primers, and 0.35 U Taq polymerase. The
PCR conditions were as follows: 94 °C for 5 min, followed
by 30 cycles of denaturation at 94 °C for 30 s, annealing at
56 °C for 30 s, extension at 72 °C for 1 min, and a final
elongation  step  at  72  °C  for  10  min.  The  reaction  was
performed in a PCR thermal cycler (GeneAmp System 9700;
Applied Biosystems, Foster City, CA). The forward primers
were labeled at the 5′ ends with 6-FAM, 3-PET, 2-VIC, or 2-
NED fluorescent dye (Sigma-Aldrich, St. Louis, Mo; Table
1). To determine the number of MS repeats, the PCR products
were denatured at 97 °C for 2 min, mixed with formamide,
and  electrophoresed  using  an  ABI3130  Genetic  Analyzer
(Applied  Biosystems).  The  number  of  MS  repeats  was
estimated by the Southern method with a GS500 TAMRA size
marker (Applied Biosystems) and automated with GeneScan
672 software (Applied Biosystems).
Statistical analysis: Allele and phenotype frequencies were
estimated by direct counting. The allelic frequencies between
the patients and controls were evaluated using Fisher’s exact
test.  The  probability  of  association  was  corrected  using
Bonferroni’s inequality method. A corrected p (pc) value of
<0.05  was  considered  statistically  significant.  Statistical
analyses were performed with SPSS software (version 10.1;
SPSS Science, Chicago, IL).
RESULTS
The  proportion  of  allele  frequencies  and  phenotype
frequencies  for  the  markers  were  consistent  with  Hardy–
Weinberg equilibrium. Table 2 shows the allele frequencies
of  MS  markers,  with  each  allele  designated  by  its
amplification  size.  The  frequency  of  the  163  allele  of
D7S1277i  was  higher  in  the  patients  than  in  the  controls
(p=0.0049,  OR=1.97,  95%CI=1.22–3.17);  however,  after
Bonferroni’s correction, the difference between the groups
was insignificant (pc=0.063).
Table  2  also  shows  the  phenotype  frequencies  of
D7S1277i  and  D7S1828  with  p<0.05.  The  163  allele  of
D7S1277i and the 369 allele of D7S1828 were associated with
the risk of NTG (p=0.0013, OR=2.47, 95%CI=1.42–4.30,
p=0.049, OR=1.70, 95%CI=1.00–2.89, respectively). After
Bonferroni’s correction, the frequency of D7S1277i 163 allele
remained  significantly  different  between  the  groups
(pc=0.016).
DISCUSSION
The  allele  frequencies  of  GLC1F  significantly  differed
between POAG patients and healthy controls in the American
population [15]. The prevalence of POAG was unrelated to
the GLC1F locus in a Finnish family, but the relationship
between GLC1F and NTG was not studied [17]. We selected
NTG patients with precise criteria because the existence of
various clinical entities can lead to a lack of statistical validity
in case-control analyses. With used 11 MS markers located in
TABLE 2. ALLELE AND PHENOTYPE FREQUENCIES OF 11 MICROSATELLITE MARKERS IN NTG CASES AND CONTROLS
 
Frequency, n (%)      
Marker Number of
detected allele
Allele* Cases
(n=141)
Controls
(n=101)
P Pc Odds ratio
(95%CI)
Allele
D7S0324i 10 171 50 (17.7) 27 (13.4) 0.20    
D7S0960i 3 429 51 (18.1) 48 (23.8) 0.13    
D7S0985i 6 462 4 (1.4) 8 (4.0) 0.076    
D7S1205i 6 158 81 (28.7) 61 (30.2) 0.73    
D7S0751i 8 359 25 (8.9) 23 (11.4) 0.36    
D7S0796i 18 418 44 (15.6) 20 (9.9) 0.068    
D7S505 9 265 8 (2.8) 3 (1.5) 0.33    
D7S1277i 13 163 70 (24.8) 29 (14.4) 0.0049 0.063 1.97 (1.22–3.17)
D7S2439 13 210 28 (9.9) 11 (5.5) 0.074    
D7S1126i 9 276 123 (43.6) 99 (49.0) 0.24    
D7S1828 6 365 100 (35.5) 89 (44.1) 0.056 0.34 0.70 (0.48–1.00)
Phenotype**
D7S1277i 13 163 65 (46.1) 26 (25.7) 0.0013 0.016 2.47 (1.42–4.30)
D7S1828 6 369 97 (68.8) 57 (56.4) 0.049 0.29 1.70 (1.00–2.89)
The asterisk indicates that alleles with >1% of frequency and found to have the most difference in allele frequency between
cases and controls in each marker are shown. Each allele was named by the size of its amplification. The double asterisk indicates
that only alleles with a p<0.05 are listed.
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464the GLC1F locus to detect an association between the GLC1F
locus  and  NTG,  and  identified  a  markedly  increased
frequency of the D7S1277i 163 allele in patients, compared
to controls (46.1% versus 25.7%).
Our data suggested that the gene(s) in the D7S1277i locus
on 7q36.1 may be significantly associated with the risk of
NTG.  D7S1277i  is  located  in  the  intron  of  the  AGAP3
(ArfGAP  with  GTPase  domain,  ankyrin  repeat  and  PH
domain 3; also known as CRAG) gene, a GTPase activating
protein  for  ADP  ribosylation  factors.  AGAP3  is  a  novel
GTPase  that  accelerates  the  degradation  of  abnormally
elongated  polyglutamine  proteins  through  intranuclear
inclusion  body  formation.  AGAP3  is  induced  by  reactive
oxygen species and inhibits the progression of polyglutamine
disease [18]. Although the association between AGAP3 and
glaucoma is unclear, AGAP3 polymorphisms may act as risk
factors in the development of NTG.
D7S1277i may be associated with other gene(s) but not
AGAP3  since  MS  markers  are  highly  polymorphic  and
generally show wide linkage disequilibriums within 100–200
kb [19-24]. Twenty genes are located within the 200 kb region
of D7S1277i. NOS3 (nitric oxide synthase 3) is located ~100
kb centromeric of D7S1277i and has been reported as a POAG
candidate gene [15]. NOS catalyzes the production of nitric
oxide (NO). NO is involved in vasodilation and the regulation
of ocular flow [25]. Ocular NO production may be important
in  the  neuroprotection  of  retinal  ganglion  cells  [26].  A
NOS3  polymorphism  was  significantly  associated  with
glaucoma with migraine, but not with NTG or POAG in a
case-control  study  [27].  Other  NOS3  polymorphisms  also
showed significant association with female POAG with high
IOP in a case-control study [28]. Therefore, NOS3 could affect
the phenotype of glaucoma patients, and a disease phenotype-
stratified analysis of NOS3 in our NTG patients is required.
In conclusion, we performed an association analysis of
the GLC1F locus using MS markers in NTG patients and
detected  an  NTG-associated  region  in  the  GLC1F  locus.
Further  studies  in  the  region  might  help  identify  the
pathogenic gene(s) of NTG.
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